Terumo Corp. (TRUMF)
14.61
-0.06
(-0.42%)
USD |
OTCM |
Dec 10, 16:00
Terumo EPS Diluted (Quarterly): 0.1611 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0253 |
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 237.70M |
| Revenue (Quarterly) | 1.865B |
| Total Expenses (Quarterly) | 1.627B |
| Enterprise Value | 21.16B |
| Gross Profit Margin (Quarterly) | 53.46% |
| Profit Margin (Quarterly) | 12.75% |
| Earnings Yield | 4.08% |
| Operating Earnings Yield | 5.90% |
| Normalized Earnings Yield | 4.082 |